-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 28, Nuocheng Jianhua announced that the new drug research (IND) application for the company's new protein tyrosine phosphatase SHP2 allosteric inhibitor ICP-189 has been accepted by the China National Medical Products Administration (NMPA)
According to the press release, ICP-189 is mainly used to treat a variety of solid tumors.